Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

10. Mai 2019 06:00 ET | Quelle: Adynxx, Inc.

Adynxx Announces Payment Date of Special Cash Dividend Previously Announced by Alliqua BioMedical

Adynxx announces May 29, 2019 as payment date of previously announced special cash dividend of $1.05 per share to former Alliqua shareholders Adynxx confirms intent to consummate the previously...
06. Mai 2019 11:05 ET | Quelle: Alliqua BioMedical, Inc

Adynxx Completes Merger with Alliqua BioMedical, Adds Pierre Legault and Matt Ruth to Board of Directors

SAN FRANCISCO, May 06, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (Nasdaq: ADYX), a clinical-stage biopharmaceutical company leading the development of transcription factor decoy technology and...
06. Mai 2019 06:00 ET | Quelle: Adynxx, Inc.

Adynxx Completes Merger with Alliqua BioMedical, Adds Pierre Legault and Matt Ruth to Board of Directors

SAN FRANCISCO, May 06, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (Nasdaq: ADYX), a clinical-stage biopharmaceutical company leading the development of transcription factor decoy technology and...
22. April 2019 08:00 ET | Quelle: Adynxx, Inc.

Adynxx Announces Merger Agreement with Alliqua BioMedical and Provides Business and Clinical Update

Adynxx announced plans to merge with Alliqua BioMedical and become a Nasdaq-listed public company in early 2019 Company announced receipt of substantial grant award from the National Institute on...